NEUTRALISING ANTIBODIES TO INTERFERON–BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS

Arie Gafson; Viki Worthington; Neghat Lakdawala; Gavin Giovannoni; Rachel Farrell

doi:10.1136/jnnp-2013-306573.176

Article info

Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013

176

NEUTRALISING ANTIBODIES TO INTERFERON–BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS

Authors

Arie Gafson University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry PubMed articles Google scholar articles
Viki Worthington University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry PubMed articles Google scholar articles
Neghat Lakdawala University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry PubMed articles Google scholar articles
Gavin Giovannoni University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry PubMed articles Google scholar articles
Rachel Farrell University College London, Institute of Neurology; Barts and The London School of Medicine and Dentistry PubMed articles Google scholar articles

Citation

Gafson A, Worthington V, Lakdawala N, et al

NEUTRALISING ANTIBODIES TO INTERFERON–BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS

Journal of Neurology, Neurosurgery & Psychiatry 2013;84:e2.

Publication history

First published October 9, 2013.

Online issue publication

April 04, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password